Skip to main content
NAUT
NASDAQ Industrial Applications And Services

Andreessen Horowitz Sells Another 1.25M Nautilus Shares, Stake Falls to 6.0%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.89
Mkt Cap
$112.71M
52W Low
$0.62
52W High
$4.31
52W Position info
44% above low
Off High info
79% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

NAUT sits 44% above its 52-week low of $0.62.

Summary

Andreessen Horowitz funds sold another ~1.25 million Nautilus shares in late July and August, reducing their stake to 6.0%. This continues a pattern of selling that began in June.


Key Events · Ownership and Investor Activity · NAUT

  • Andreessen Horowitz Sells 1.25M Shares

    AH Bio II and AH LSV II sold approximately 1.25 million shares in open market transactions between July 31 and August 27, 2026, at prices ranging from $0.90 to $1.06 per share.

  • Stake Reduced to 6.0%

    The group's aggregate beneficial ownership fell to 7,684,932 shares, representing 6.0% of Nautilus's 127.3 million outstanding shares as of July 24, 2026.

  • Continued Selling Pressure

    This follows prior sales in June 2026 that reduced the stake from earlier levels, indicating a sustained exit by a major early investor.

  • Context: Delayed Product Timeline

    The selling comes after Nautilus indefinitely delayed its broadscale assay and pushed out the commercial timeline in July 2026, which may be contributing to reduced investor conviction.


Analysis · NAUT · Industrial Applications And Services

Andreessen Horowitz funds continued their exit from Nautilus Biotechnology, selling roughly 1.25 million shares between July 31 and August 27 at prices between $0.90 and $1.06. This follows prior sales in June that already cut their stake significantly. The group now holds 7.68 million shares, or 6.0% of the company, down from earlier levels. The persistent selling by a major early investor adds downward pressure on the stock and signals reduced conviction in the company's near-term prospects, especially after Nautilus delayed its broadscale assay indefinitely in July.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 29.9% of the 1988 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NAUT was trading at $0.89 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $112.7M. The 52-week trading range was $0.62 to $4.31. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NAUT - Latest Insights

NAUT
Aug 14, 2026, 5:20 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.910
Real-time Price: $1.02 info
Change: +$0.105 (+12%) info
Market Cap: $129.164M info
NAUT
Jul 28, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $1.02 info
Change: -$0.185 (-15%) info
Market Cap: $129.164M info
NAUT
Jul 28, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.51
Real-time Price: $1.02 info
Change: -$0.495 (-33%) info
Market Cap: $129.164M info
NAUT
Jul 27, 2026, 7:29 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $1.02 info
Change: -$0.705 (-41%) info
Market Cap: $129.164M info
NAUT
Jun 30, 2026, 5:13 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.87
Real-time Price: $1.02 info
Change: -$0.855 (-46%) info
Market Cap: $129.164M info